NEW YORK, June 26 (Reuters) - Wyeth (WYE.N: Quote, Profile, Research) on Monday said it has asked U.S. regulators to approve two new prescription drugs for postmenopausal women, one to prevent osteoporosis and the other to treat moderate to severe symptoms of menopause.
The Madison, New Jersey-based drugmaker said it had asked the U.S. Food and Drug Administration to approve bazedoxifene -- a member of the selective estrogen receptor modulator (SERM) class of drugs -- to prevent postmenopausal osteoporosis.
It said it also asked the FDA to approve desvenlafaxine succinate, a non-hormonal drug to treat vasomotor symptoms of menopause, such as hot flashes and night sweats.
© Reuters 2006. All Rights Reserved.
Labels: No Prescription, Online Pharmacy, Prescription Drugs
# posted by Network @ 4:47 PM
